CHCO
City Holding Company
CHCO's fundamentals are mixed: revenue grew 6.3%, while its operating margin held steady at 50%. At 16x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
CHCO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
CHCO's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CHCO.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
CHCO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 13x | $116 | -18% |
| Fair | 14x | $130 | -8.5% |
| Expensive | 15x | $141 | -1% |
| Forward | 15x | $142 | — |
| Current | 16x | $142 | — |
Historical ranges are pointers, not guarantees.
CHCO's PE is in its expensive range at 16x. If earnings grow as analysts expect, today's price would be 15x next year's earnings.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
CHCO Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect CHCO's earnings to grow and its profitability to improve, with its revenue holding steady.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CHCO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.53 | +4.2% |
| Q3 2026 | $9.15 | +5.2% |
| Q2 2026 | $9.13 | +9.9% |
| Q1 2026 | $9.07 | +14% |
| Q4 2025 | $8.93 | +13% |
| Q3 2025 | $8.70 | +12% |
| Q2 2025 | $8.31 | +7.2% |
| Q1 2025 | $7.98 | +0.4% |
| Q4 2024 | $7.89 | +3.7% |
CHCO has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
CHCO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $84M | +3.4% |
| Q2 2026 | $81.5M | +4.3% |
| Q1 2026 | $79.2M | +6.3% |
| Q4 2025 | $80.2M | +12% |
| Q3 2025 | $81.3M | +7% |
| Q2 2025 | $78.2M | +6.3% |
| Q1 2025 | $74.6M | +3% |
| Q4 2024 | $71.7M | +4.1% |
CHCO's revenue has grown year over year for nine quarters in a row: $84M last quarter, up 3.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 51% | -2.5 points |
| Q2 2026 | 51% | -2 points |
| Q1 2026 | 50% | 0 points |
| Q4 2025 | 49% | +1.2 points |
| Q3 2025 | 54% | +5.1 points |
| Q2 2025 | 53% | +3.3 points |
| Q1 2025 | 50% | -1.1 points |
| Q4 2024 | 48% | -1.4 points |
CHCO has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
CHCO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $35.1M | -1.8% |
| Q2 2026 | $31.8M | +14% |
| Q1 2026 | $37.3M | +19% |
| Q4 2025 | $33.6M | +2.4% |
| Q3 2025 | $35.8M | -3.4% |
| Q2 2025 | $27.8M | +0.1% |
| Q1 2025 | $31.3M | -1% |
| Q4 2024 | $32.8M | -0.5% |
CHCO has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
CHCO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -13K shares |
| 1 year | -2.9% | -414K shares |
| 3 years | -6% | -896K shares |
| 5 years | -8.2% | -1.3M shares |
| Available history | -13% | -2.2M shares |
CHCO has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $7.3M |
| Q1 2026 | $30.9M |
| Q4 2025 | $16.9M |
| Q3 2025 | — |
| Q2 2025 | $19.4M |
| Q1 2025 | $9.5M |
| Q4 2024 | — |
CHCO spent $55M buying back its own shares over the past year, up 90% from the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CHCO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | -0.5x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -1.6x | Net Cash |
| Q4 2024 | -0.5x | Net Cash |
CHCO has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like CHCO.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
CHCO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.4 | Neutral |
| Stochastic | 38.6 | Neutral |
CHCO's weekly RSI is 58 (neutral) and its Stochastic is 39 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
CHCO PE vs Financial Services Sector
| Metric | CHCO | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 13x | 19% above |
| PE % | 86 | 63 | 23 pts above |
CHCO is trading at 16x earnings, a 19% premium to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
CHCO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $141.8 | 0.1% above |
| 20 week MA | $141.8 | 0.1% above |
| 50 week MA | $131.0 | 8.4% above |
| 100 week MA | $125.7 | 13% above |
| 200 week MA | $114.2 | 24% above |
CHCO has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
CHCO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $82.3 | $69.5 | -16% |
| 2021 | $69.5 | $81.2 | +17% |
| 2022 | $81.2 | $93.5 | +15% |
| 2023 | $93.5 | $110.3 | +18% |
| 2024 | $110.3 | $121.1 | +9.8% |
| 2025 | $121.1 | $123.8 | +2.3% |
| 2026 YTD | $123.8 | $142.0 | +15% |
CHCO has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.